Ersoy, M. (2026) “Can Immature Granulocytes Guide Chemotherapy Decisions in Later Lines of Therapy for HER2-Negative Breast Cancer?”, The European Research Journal, 12(1), pp. 86–96. doi:10.18621/eurj.1764519.